Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trialsUwe Zeymer, Hölger Thiele, Anne Freund et al.|The Lancet|2023Cited by 194
Studying Brugada Syndrome With an SCN1B Variants in Human-Induced Pluripotent Stem Cell-Derived CardiomyocytesIbrahim El‐Battrawy, İbrahim Akın|Frontiers in Cell and Developmental Biology|2019Cited by 35
TRPV1 activation and internalization is part of the LPS-induced inflammation in human iPSC-derived cardiomyocytesKatherine Sattler, İbrahim Akın|Scientific Reports|2021Cited by 29
Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene‐edited human‐induced pluripotent stem cell‐derived cardiomyocytes and preclinical drug screeningIbrahim El‐Battrawy, Xiaobo Zhou, Lasse Maywald et al.|Clinical and Translational Medicine|2021Cited by 22
Use of the Wearable Cardioverter‐Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter RegistryIbrahim El‐Battrawy, Thomas Beiert, Katharina Koepsel et al.|Journal of the American Heart Association|2023Cited by 17